Published 2 years ago • loading... • Updated 2 years ago
The FDA reverses its ban on Juul e-cigarettes
FDA cited insufficient evidence on JUUL's products' toxicological profile, causing concern over genotoxicity and harmful chemicals leaching from e-liquid pods. This halted a full toxicological review, leading to an initial denial.
E-Cigarette products, including JUUL's, require FDA authorization for legal marketing. The ongoing review process emphasizes this necessity.
The FDA's rescission of the marketing ban does not indicate authorization or denial, returning applications to pending status for substantive review under regulatory constraints.